On Tuesday, Senseonics Holdings Inc (AMEX: SENS) was 4.96% up from the session before settling in for the closing price of $0.42. A 52-week range for SENS has been $0.25 – $1.40.
During the last 5-year period, the sales growth of Healthcare Sector giant was 27.24%. When this article was written, the company’s average yearly earnings per share was at 36.90%. With a float of $710.30 million, this company’s outstanding shares have now reached $814.58 million.
Senseonics Holdings Inc (SENS) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Senseonics Holdings Inc stocks. The insider ownership of Senseonics Holdings Inc is 12.81%, while institutional ownership is 18.61%. The most recent insider transaction that took place on Dec 12 ’24, was worth 123,000. In this transaction Director of this company bought 300,000 shares at a rate of $0.41, taking the stock ownership to the 1,388,087 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director bought 25,000 for $0.50, making the entire transaction worth $12,500. This insider now owns 1,413,087 shares in total.
Senseonics Holdings Inc (SENS) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.04 earnings per share (EPS) during the time that was better than consensus figure (set at -0.04) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.38% during the next five years compared to 27.24% growth over the previous five years of trading.
Senseonics Holdings Inc (AMEX: SENS) Trading Performance Indicators
You can see what Senseonics Holdings Inc (SENS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.09 in one year’s time.